TITLE

FDA Bows to Industry: OKs Risky Kind of Breast Implant

AUTHOR(S)
Erickson, Jan
PUB. DATE
January 2007
SOURCE
National NOW Times;Winter2007, Vol. 39 Issue 1, p15
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article scrutinizes the move of the U.S. Food and Drug Administration (FDA) to issue final approval to Allergan Inc. and Mentor Corp. to market their risky silicone gel-filled breast implants to women aged 22 and older. The FDA has ignored disclosures that Mentor had failed to report accurate information about levels of a form of oxidized platinum in the implants that is known to be harmful to humans. Several U.S. legislators have expressed concern over the move.
ACCESSION #
23875343

 

Related Articles

  • FDA approves silicone devices.  // Dermatology Times;Dec2006, Vol. 27 Issue 12, p40 

    The article reports that in November 2006, the U.S. Food and Drug Administration (FDA) approved the sale of silicone gel breast implants by Mentor Corp. and Allergen. The sale of these devices was banned for the last 14 years. According to FDA officials, no convincing evidence has been found...

  • Silicone Gel-Filled Breast Implants Approved.  // FDA Consumer;Jan/Feb2007, Vol. 41 Issue 1, p8 

    The article reports on the approval of the marketing of silicone gel-filled breast implants made by Allergan Corp. and Mentor Corp. by the Food and Drug Administration (FDA) after a scientific review in the U.S. The two implants are for breast reconstruction in women of all ages and breast...

  • GEL ETHICS TO REPLACE OR NOT TO REPLACE? Jesitus, John // Cosmetic Surgery Times;Jan/Feb2007, Vol. 10 Issue 1, p20 

    The article discusses the significance of switching implants from saline to silicone, based from the opinions given by some U.S. surgeons. According to Amy E. Newburger, many doctors will replace such implants, but it is not what the Food and Drug Administration clearance means. Meanwhile,...

  • Breast implant manufacturers settle medical subrogation...  // Business Insurance;12/02/96, Vol. 30 Issue 49, p1 

    Reports on the agreement made by five silicone breast implant makers in the United States, to pay $50 million, to settle a medical subrogation case. First time that health care payers have recovered medical expenses on such a large scale; Healthcare Recoveries Incorporated's initiation of an...

  • Women's lobby wins Ottawa's support for breast implant protest. Mitchell, Penni // Herizons;Fall94, Vol. 8 Issue 3, p6 

    Reports on the plans of several provincial governments in Canada to intervene in behalf of women to oppose the proposed settlement from the United States-based manufacturers of faulty breast implants. Restriction for foreign claimants to a combined limit of three per cent of the total...

  • Bill signed to protect manufacturers of biomaterials used in medical implants.  // Chemical Market Reporter;09/07/98, Vol. 254 Issue 10, p25 

    Reports that United States President Bill Clinton has signed into law legislation that will provide legal protection to suppliers of biomaterials in liability lawsuits involving allegedly faulty medical implants. Significance of the legislation as a way to avert a public health crisis; Outcome...

  • IMPLANTS: MIXED O.K. Bjerklie, David // Time;10/27/2003, Vol. 162 Issue 17, p79 

    Reports that a Food and Drug Administration advisory panel voted 9 to 6 to recommend that silicone breast implants be allowed back on the market. Their sale was halted in 1992 because of concerns that leaking implants could cause serious illness. Later studies found no evidence that implants...

  • Implant suits expected.  // Hudson Valley Business Journal;9/18/95 - 9/25/95, Vol. 6 Issue 36, p26 

    Reports on the expected influx of breast implant lawsuits in the United States due to the pending decision of US District Court Judge Sam Pointer to kill a $4.25 billion settlement of the health claims. Settlement's insufficiency due to the number of women with health claims.

  • Silicone: Juries vs. science. Cowley, Geoffrey; Springen, Karen // Newsweek;11/13/1995, Vol. 126 Issue 20, p75 

    Reports that Charlotte Mahlum was awarded $4 million in compensatory damages from Dow Chemical Co., plus $10 million in punitive damages concerning her silicone breast implants. Illnesses Muhlum alleges are from the silicone; Studies failing to link silicone breast implants to illnesses; Dow...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics